Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE

被引:81
|
作者
Olivier, Chamion N. [1 ]
Blake, Ruth K. [1 ]
Steed, Lisa L. [1 ]
Salgado, Cassandra D. [1 ]
机构
[1] Med Univ S Carolina, Charleston, SC 29425 USA
来源
关键词
D O I
10.1086/587647
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BACKGROUND. Colonization with vancomycin-resistant Enterococcus (VRE) is a risk factor for subsequent VRE bloodstream infection ( BSI); however, risk factors for BSI among colonized patients have not been adequately described. We sought to determine the proportion of VRE-colonized patients who subsequently develop VRE BSI and to identify risk factors for VRE BSI among these patients. METHODS. Records of 768 patients colonized with VRE from January 2002 through June 2005 were reviewed. The proportion of patients who developed VRE BSI was calculated, and the characteristics of these patients were compared, in a 2 : 1 ratio, with those of patients who did not develop VRE BSI. To identify risk factors for VRE BSI and for death, we used univariate logistic regression analysis and then multivariate logistic regression analysis. Using pulsed-field gel electrophoresis (PFGE), we compared the isolate recovered when the patient was colonized and the isolate recovered when the patient developed VRE BSI. RESULTS. Of the 768 patients colonized with VRE, 31 (4.0%) developed VRE BSI. Multivariate analysis identified the following idependent risk factors for developing VRE BSI: infection of an additional body site other than blood (adjusted odds ratio [aOR], 3.9; P = .04), admission to the hospital from a long-term care facility (aOR, 12.6; P = .04), and receipt of vancomycin (aOR, 10.6; P < .001). The independent risk factors for death among patients colonized with VRE were immunosuppression (aOR, 12.9; P = .001) and VRE BSI (aOR, 9.1 P =.002). Of the 31 patients who developed VRE BSI, 23 (74%) had a pair of isolates representing VRE colonization and VRE BSI. For 19 (83%) of these 23 patients, the isolate representing BSI was genetically related to the isolate representing VRE colonization: 12 pairs of isolates (52%) had identical banding patterns, 5 had closely related patterns, and 2 had possibly related patterns. CONCLUSION. Of the 768 patients colonized with VRE, 31 (4.0%) usually developed VRE BSI due to a related strain. Independent risk factors for BSI among colonized patients were admission from a long-term care facility, infection of an additional body site, and exposure to vancomycin. Independent risk factors for death were immunosuppression and VRE BSI.
引用
收藏
页码:404 / 409
页数:6
相关论文
共 50 条
  • [1] Risk factors for vancomycin-resistant Enterococcus (VRE) infection in colonized patients with cancer
    Husni, R
    Hachem, R
    Hanna, H
    Raad, I
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2002, 23 (02): : 102 - 103
  • [2] A VANCOMYCIN-RESISTANT ENTEROCOCCUS (VRE) SCREEN TO PREDICT VRE BLOODSTREAM INFECTION IN THE ICU
    Kram, Shawn
    McRae, Andrew
    Schultheis, Jennifer
    Kram, Bridgette
    CRITICAL CARE MEDICINE, 2018, 46 (01) : 317 - 317
  • [3] Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE
    Bossaer, John B.
    Hall, Philip D.
    Garrett-Mayer, Elizabeth
    SUPPORTIVE CARE IN CANCER, 2011, 19 (02) : 231 - 237
  • [4] Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE
    John B. Bossaer
    Philip D. Hall
    Elizabeth Garrett-Mayer
    Supportive Care in Cancer, 2011, 19 : 231 - 237
  • [5] Vancomycin-Resistant Enterococcus (VRE) Transmission and Risk Factors in Contacts of VRE Carriers
    Kaki, Reham
    Yu, Yang
    O'Neill, Cindy
    Lee, Christine
    Mertz, Dominik
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2014, 35 (07): : 876 - 879
  • [6] Risk of vancomycin-resistant enterococci bloodstream infection among patients colonized with vancomycin-resistant enterococci
    Kara, Ahu
    Devrim, Ilker
    Bayram, Nuri
    Katipoglu, Nagehan
    Kiran, Ezgi
    Oruc, Yeliz
    Demiray, Nevbahar
    Apa, Hursit
    Gulfidan, Gamze
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2015, 19 (01): : 58 - 61
  • [7] Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia
    Roghmann, MC
    McCarter, RJ
    Brewrink, J
    Cross, AS
    Morris, JG
    CLINICAL INFECTIOUS DISEASES, 1997, 25 (05) : 1056 - 1059
  • [8] Nosocomial vancomycin-resistant enterococcal blood stream infection (VRE-BSI) development in oncology patients colonized with vancomycin-resistant Enterococci(VRE-C)
    Zaas, AK
    Song, XY
    Perl, TM
    Tucker, PC
    CLINICAL INFECTIOUS DISEASES, 2000, 31 (01) : 278 - 278
  • [9] Vancomycin-resistant Enterococcus (VRE) carriage and infection in intensive care units
    Yeh, KM
    Siu, LK
    Chang, JC
    Chang, FY
    MICROBIAL DRUG RESISTANCE, 2004, 10 (02) : 177 - 183
  • [10] First outbreak of vancomycin-resistant enterococcus (VRE) in Japan
    Atarashi, K
    Baba, K
    Fujiki, K
    Takamoto, T
    Nishimura, H
    Oana, K
    Honda, T
    Katsuyama, T
    Seki, N
    Suzuki, H
    Inase, N
    Yoshizawa, Y
    CLINICAL INFECTIOUS DISEASES, 2000, 31 (01) : 279 - 279